A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to evaluate if DVS SR is safe and effective in the treatment of pain associated with fibromyalgia syndrome, and if so to identify the efficacious doses.

Key facts

Study ID
NCT00696787
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
125
Starts
2008-06-01
Expected to finish
2009-01-01
Last updated by the study team
2013-02-25

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.